Enveric Biosciences Inc.

ENVB | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.54

-$0.02 (-1.28%)

At close: Sep 22, 2026, 4:00 PM ET

$1.59

+$0.05 (+3.25%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.28%

(1D)

Rating

Updated: Sep 4, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $919.4K

1D Range

1.52 1.61

52W Range

1.17 13.25

Valuation (TTM)

PE -0.09

PB 0.12

EV/EBITDA 0.86

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -919.2%

SBC Adj. FCF Yield -988.1%

SBC Impact -7.5%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 0.8% | -37.0%

FCF 3Y | 5Y 8.5% | 22.4%

Returns

ROA -97.6%

ROE -168.1%

ROIC -108.0%

Financial Health

Net Cash

$8.3M

Current Ratio 10.21

Interest Coverage -10,329.56

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, d...

Sector Healthcare

Industry Biotechnology

Employees 6

IPO Date May 3, 2015

Website www.enveric.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.